1. "Gastrointestinal Oncology Service"
Formats
  1. Journal Article (2302)
  2. Meeting Abstract (1841)
  3. Review (139)
  4. Book Section (123)
  5. Editorial (93)
  6. Guidelines (36)
  7. Correspondence (33)
  8. Conference Paper (23)
  9. Miscellaneous (21)
  10. Research Letter (17)
  11. Book Whole (12)
Groups
  1. Gastrointestinal Oncology Service (4640)
  2. Solid Tumor Oncology Division (4640)
  3. Department of Medicine (4638)
  4. Center for Pancreatic Cancer Research (2270)
  5. Surgery (1040)
  6. Survivorship Research (992)

More Groups

People
  1. Leonard Saltz (790)
  2. Eileen O'Reilly (780)
  3. Ghassan Abou-Alfa (568)
  4. Nancy Kemeny (543)
  5. David Kelsen (537)
  6. David Ilson (433)

More People

Years
  1. 2025 (118)
  2. 2024 (307)
  3. 2023 (362)
  4. 2022 (346)
  5. 2021 (345)
  6. 2020 (326)

More Years

Publications
  1. Journal of Clinical Oncology (1276)
  2. Annals of Oncology (320)
  3. Annals of Surgical Oncology (140)
  4. Cancer (127)
  5. Clinical Cancer Research (107)
  6. Cancer Research (94)

More Publications

Publishers
  1. American Society of Clinical Oncology (1355)
  2. Oxford University Press (447)
  3. Elsevier Inc. (404)
  4. Springer (310)
  5. American Association for Cancer Research (279)
  6. Wiley Blackwell (239)

More Publishers

Results (4640)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase Ib dose-escalation and cohort-expansion study of safety and activity of the transforming growth factor (TGF) β receptor I kinase inhibitor galunisertib plus the anti-PD-L1 antibody durvalumab in metastatic pancreatic cancer
    Meeting Abstract

    Melisi, D.; Hollebecque, A.; Oh, D. Y.; Calvo, E.; Varghese, A. M.; Borazanci, E. H.; Mercade, T. M.; Simionato, F.; Park, J. O.; Bendell, J. C.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Trifluridine/tipiracil (FTD/TPI) in patients (pts) with metastatic gastroesophageal junction cancer (mGEJC): Subgroup analysis from TAGS
    Meeting Abstract

    Mansoor, W.; Arkenau, H. T.; Alsina, M.; Shitara, K.; Tejani, M. A.; Thuss-Patience, P. C.; Cuffe, S.; Dvorkin, M.; Park, D.; Ando, T.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Evaluating gender as a predictive marker for response to bevacizuamb (Bev) in metastatic colorectal carcinoma (mCRC): Pooled analysis of 3369 patients (pts) in the ARCAD database
    Meeting Abstract

    Margalit, O.; Harmsen, W. S.; Shacham-Shmueli, E.; Petersen, M.; Boursi, B.; Saltz, L. B.; Adams, R.; Maughan, T.; Douillard, J. Y.; Van Cutsem, E.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Impact of geriatric vulnerability on outcomes of older patients in allogeneic hematopoietic cell transplantation
    Meeting Abstract

    Lin, R. J.; Elko, T. A.; Devlin, S. M.; Flynn, J.; Jakubowski, A. A.; Shahrokni, A.; Dahi, P.; Perales, M. A.; Sanchez-Escamilla, M.; Tamari, R.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Characterization and clinical outcomes of mismatch repair deficient (dMMR) small bowel adenocarcinoma (SBA)
    Meeting Abstract

    Latham, A.; Reidy, D. L.; Segal, N. H.; Yaeger, R.; Ganesh, K.; Connell, L. C.; Kemeny, N. E.; Shia, J.; Hechtman, J. F.; Srinivasan, P.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Randomized phase II trial of adjuvant hepatic arterial infusion (HAI) + systemic FOLFIRI +/- panitumumab (Pmab) in patients with resected RAS wild type colorectal cancer hepatic metastases (CRLM)
    Meeting Abstract

    Kemeny, N. E.; Hauser, H.; Capanu, M.; Kingham, T. P.; Jarnagin, W. R.; DeMatteo, R. P.; Cercek, A.; Balachandran, V. P.; Drebin, J. A.; D'Angelica, M. I.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Infigratinib versus gemcitabine plus cisplatin multicenter, open-label, randomized, phase 3 study in patients with advanced cholangiocarcinoma with FGFR2 gene fusions/translocations: The PROOF trial
    Meeting Abstract

    Javle, M. M.; Borbath, I.; Clarke, S. J.; Hitre, E.; Louvet, C.; Mercade, T. M.; Oh, D. Y.; Spratlin, J. L.; Valle, J. W.; Weiss, K. H.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • KEYNOTE-811 pembrolizumab plus trastuzumab and chemotherapy for HER2+ metastatic gastric or gastroesophageal junction cancer (mG/GEJC): A double-blind, randomized, placebo-controlled phase 3 study
    Meeting Abstract

    Janjigian, Y. Y.; Bang, Y. J.; Fuchs, C. S.; Qin, S.; Satoh, T.; Shitara, K.; Tabernero, J.; Van Cutsem, E.; Cao, Z. A.; Chen, X.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • First-line pembrolizumab (P), trastuzumab (T), capecitabine (C) and oxaliplatin (O) in HER2-positive metastatic esophagogastric adenocarcinoma
    Meeting Abstract

    Janjigian, Y. Y.; Maron, S. B.; Chou, J. F.; Gabler, A.; Simmons, M.; Momtaz, P.; Sanchez-Vega, F.; Shcherba, M.; Ku, G. Y.; Won, E.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Molecular circulating tumor DNA response to identify long-term survival in patients receiving immunotherapy with initial radiologic stable disease
    Meeting Abstract

    Hellmann, M. D.; Zhang, Q.; Abdullah, S. E.; Chaft, J. E.; Segal, N. H.; Gao, C.; Dennis, P. A.; Higgs, B. W.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save